Statera Biopharma, Inc. (STAB)
OTCMKTS: STAB · Delayed Price · USD
0.0003
-0.0003 (-50.00%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Statera Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2021202020192018201720162015201420132012 2011 - 2006
Net Income
-174.41-13.22-3.35-3.61-9.71-2.66-12.641,629-17,262.88-18,234.14
Upgrade
Depreciation & Amortization
0.2600.010.020.020.060.14200.79376.21479.6
Upgrade
Share-Based Compensation
6.060.010000.010.1496.471,4732,535
Upgrade
Other Operating Activities
139.98.133.09-1.023.07-2.460.32-16,781.55-7,689.43-5,430.17
Upgrade
Operating Cash Flow
-28.19-5.08-0.24-4.61-6.61-5.04-12.08-14,455.19-23,102.65-20,649.5
Upgrade
Capital Expenditures
-0.18-0.0100000000
Upgrade
Acquisitions
13.65000000000
Upgrade
Change in Investments
--1.41-2.6-19.43-21.15-39.94-20.06-3,097.84-2,197.94-13,532.9
Upgrade
Other Investing Activities
-1.412.7523.425.0345.619.781,3112,75914,905
Upgrade
Investing Cash Flow
13.46-0.010.163.973.895.67-10.28-1,786.74560.711,372
Upgrade
Common Stock Issued
7.342.780000.5427.199,698015,676
Upgrade
Other Financing Activities
13.642.90.230.06---2.25892.537,2625,844
Upgrade
Financing Cash Flow
20.995.680.230.0600.5424.9410,5907,26221,519
Upgrade
Net Cash Flow
6.250.59-0.01-0.61-2.670.982.81-6,944.5-15,603.622,779
Upgrade
Free Cash Flow
-28.38-5.09-0.24-4.61-6.61-5.04-12.08-14,455.19-23,102.65-20,649.5
Upgrade
Free Cash Flow Per Share
-0.81-0.20-0.01-0.41-0.59-0.46-1.71-5.35-0.51-0.55
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.